Brazil authorizes import of raw material to produce Chinese COVID-19 vaccine

BRASILIA (Reuters) - Brazil's health regulator Anvisa said on Wednesday it has authorized the import of raw materials from Chinese company Sinovac for the production of its COVID-19 vaccine.

Sao Paulo's biomedical institute Butantan plans to produce the vaccine.

(Reporting by Ricardo Brito, writing by Stephen Eisenhammer, editing by Chris Reese)